previously published (17) . XO (EC 1.1. 3.22) and hypoxanthine were from Serva (Heidelberg, Germany), horseradish peroxidase (HRP)(Type VI-A) and lactoperoxidase (EC 1.11.1.7.) from Sigma Chemical Co. (Deisenhofen, Germany), β-naphthoflavone from Aldrich Chemical Co. (Milwaukee, WI, USA), NADPH and DNA (from calf thymus) (CT-DNA) from Boehringer (Mannheim, Germany). Enzymes and chemicals for the 32 P-post-labelling assay were obtained commercially from sources described previously (17) .
Purity of AAI and AAII
Analytical high performance liquid chromatography (HPLC) was performed on a Hewlett-Packard 1090 liquid chromatograph with a Bischoff fluorescence HPLC monitor 8400 as described (17) . Purity of AAI and AAII was determined to be 99%. Fluorescence monitoring showed traces of the corresponding lactams (Ͻ0.05%) as impurities of both acids.
Instrumentation
Analytical HPLC was performed on a Hewlett-Packard HP 1090 liquid chromatograph equipped with a Berthold LB 506 C-1 radioactivity monitor. Quantitation of 32 P-labelled adducts was carried out by measuring Cerenkov radiation on spots excised from thin-layer chromatography (TLC) plates with a Packard Tri-Carb 2000 CA liquid scintillation counter.
In vitro incubations with microsomes
Six male Sprague-Dawley rats (about 100-150 g) were injected i.p. with β-naphthoflavone dissolved in maize oil (60 mg/kg body wt) once a day for Fig. 1 . Metabolic activation and DNA adduct formation of AAI and AAII. 1 three consecutive days. The animals were starved for 16-18 h after the last RϭOCH 3 , AAI; RϭH , AAII; 2 cyclic nitrenium ion of AAI or AAII; 3 administration of β-naphthoflavone prior to being killed, and liver microsomes RϭOCH 3 , aristolactam I; RϭH, aristolactam II; 4 RϭOCH 3 , containing cytochrome P450 and NADPH:cytochrome P450 reductase were 7-(deoxyadenosin-N 6 -yl)-aristolactam I (dA-AAI); RϭH, 7-(deoxyadenosinprepared as described by Kimura et al. (18) and pooled microsomal fractions N 6 -yl)-aristolactam II (dA-AAII); 5 RϭOCH 3 , 7-(deoxyguanosin-N 2 -yl)-(100 000 g sediment) stored at -70°C. Incubations were performed essentially aristolactam I (dG-AAI); RϭH, 7-(deoxyguanosin-N 2 -yl)-aristolactam II as described (19, 20) . The deaerated and argon-purged incubation mixtures (dG-AAII).
contained in a final volume of 0.75 ml: 50 mM potassium phosphate buffer pH 7.4; 2 mM NADPH; 3.5 mg microsomal proteins; 0.3 mM AAI or AAII lipoyl dehydrogenase and DT-diaphorase are known to as sodium salts dissolved in water and 1 mg DNA (4 mM). Incubations were catalyse nitro-reduction in mammalian tissues (10) .
carried out at 37°C for 60 min also under air. Control incubations were Cytochromes P450 (P450s) also participate in the hepatic performed either without microsomes or without AAs or without DNA.
microsomal reduction under several conditions (10, 12, 13) .
In vitro incubations with peroxidases
Previously, we reported that XO catalysed the reductive
The deaerated and argon-purged incubation mixtures contained in a final activation of AAI and AAII to metabolites binding to DNA volume of 0.75 ml: 50 mM potassium phosphate buffer pH 6.0; 0.1 mg horse (14) and identified the main DNA adducts formed (15, 16 Materials for the 32 P-post-labelling assay were the same as described previously (22 ) . Nuclease P1, deoxyadenosine 3Ј-monophoshate (dAp) and deoxyguanos-
Material and methods
ine 3Ј-monophosphate (dGp) were obtained from Sigma Chemical Co.
Chemicals and enzymes
(Deisenhofen, Germany). For the standard procedure of the 32 P-post-labelling method 1 µg of DNA was digested and 32 P-labelled using 100 µCi of [γ-32 P]-AAI and AAII were separated from the mixture AA by preparative HPLC chromatography and chemically reduced to the corresponding lactams as ATP purchased from ICN Biomedicals GmbH (Meckenheim, Germany) with a sp. act. of 7000 Ci/mmol as previously described (22) . The nuclease-P1 enrichment version was performed by digesting DNA samples (12.5 µg) with micrococcal nuclease (750 mU) and spleen phosphodiesterase (12.5 mU) in digestion buffer (20 mM sodium succinate, 8 mM CaCl 2 , pH 6.0) for 3 h at 37°C in a total volume of 12.5 µl. Here, 2.5 µl of the digests were removed and diluted 1:1500 to determine the amount of normal nucleotides. Digests (10 µl) were enriched for adducts by incubation with 5 µg (5U) nuclease P1 in 3 µl of a buffer containing 0.8 M sodium acetate, pH 5.0, 2 mM ZnCl 2 for 30 min at 37°C. The reaction was stopped by adding 3 µl of 427 mM tris base. Four microlitres of labelling mix consisting of 400 mM bicine pH 9.5, 200 mM dithiotreitol, 200 mM MgCl 2 , 10 mM spermidine, 100 µCi [γ-32 P]-ATP (15 pmol), 0.5 µl 90 µM ATP and 10 U T4 polynucleotide kinase were added. After incubation for 30 min at room temperature, 20 µl were applied to a PEI-coated cellulose TLC plate (Macherey-Nagel, Düren, Germany) and chromatographed as described (14) except that D3 and D4 were adjusted to pH 4.0 and 9.1 for better resolution. For determination of the amount of normal nucleotides 5 µl of the 1:1500 dilution of digests were mixed with 2.5 µl of tris buffer (10 mM, pH 9.0) and 2.5 µl of labelling mix (see above) and incubated for 30 min at room temperature. The labelling mixture was diluted by mixing 4 µl with 750 µl of 10 mM tris buffer, pH 9.0. 5 µl of this solution were applied to a PEI-TLC plate and run in 0.28 M (NH 4 ) 2 SO 4 , 50 Fig. 2 . Autoradiographic profiles of AAI-DNA adducts obtained from: (A) mM NaH 2 PO 4 , pH 6.5.
forestomach of Sprague-Dawley rats treated with AAI as reported before Adducts and normal nucleotides were detected by autoradiography and spots (17); (B) CT-DNA after activation by either hepatic microsomes; (C) or were excised from the chromatograms for Cerenkov counting. Count rates of XO; (D) or Zn at pH 5.8; (E) or HRP and (F) or lactoperoxidase. The adducted fractions were determined from triplicate maps after subtraction of nuclease P1-enrichment procedure was used for analysis, except for (D) count rates from adjacent blank areas. Excess [γ-32 P]ATP after the postwhere the standard method was used. Origins, in the bottom left-hand labelling reaction was confirmed. Adduct levels were calculated in units of corner were cut off before exposure. Screen enhanced autoradiography was relative adduct labelling (RAL) which is the ratio of cpm of adducted at room temperature from 30 min to 2 h. Chromatographic conditions: D1, nucleotides to cpm of total nucleotides in the assay.
1 M sodium phosphate, pH 6.8; D3, 3.5 M lithium formate, 8.5 M urea, pH Preparation and 32 P-post-labelling analysis of reference compounds, dAp-4.0; D4, 0.8 M LiCl, 0.5 M Tris-HCl, 8.5 M urea, pH 9.1; D5, 1.7 M AAI, dGp-AAI, dAp-AAII and dGp-AAII were carried out as described NaH 2 PO 4 , pH 6.0. Spot 1, dG-AAI; spot 2, dA-AAI; spot 3, dA-AAII; spots earlier (17).
5 and 8, unknown.
Co-chromatography on PEI-cellulose
Adduct spots detected by the 32 P-post-labelling assay were excised from the anaerobic conditions. In contrast, control incubations carried out thin-layer plates and extracted as described (23) . For co-chromatographic analyses the dried extracts were dissolved in water so that equal amounts of in parallel either without enzymes, microsomes or Zn, or without radioactivity could be applied for each sample. Chromatograms were developed DNA, or without AAI were free of adduct spots in the region of as described above, but only in D3 and D4 directions. interest even after prolonged exposure times. Spots 1, 2 and 3
HPLC analysis of 32 P-labelled 3Ј,5Ј-deoxyribonucleoside bisphosphate
were characterized by co-chromatography on PEI-cellulose adducts (data not shown) and by reversed-phase HPLC (Figure 3 ) with HPLC analysis was performed as described previously (17, 24) . Briefly, those of synthetic standards as described previously (17) . Thus, individual spots detected by the 32 P-post-labelling assay were excised from spot 1 was assigned to 3Ј,5Ј-bisphospho-7-(deoxyguanosin-N 2 -thin layer plates and extracted (23) . The extracts redissolved in sterile water were analysed on a phenyl-modified reverse-phase column with a gradient of yl)-aristolactam I (dG-AAI), spot 2 to 3Ј,5Ј-bisphospho -7-methanol in aqueous 0.5 M sodium phosphate and 0.5 M phosphoric acid pH (deoxyadenosin-N 6 -yl)-aristolactamI (dA-AAI) and spot 3 to 3.5 and peaks detected by monitoring Cerenkov radiation as described (17) .
3Ј,5Ј-bisphospho-7-(deoxyadenosin-N 6 -yl)-aristolactamII (dA-AAII). The same chromatographic profiles of adduct spots were Results obtained from analysis of the forestomach of rats treated with AAI and reported previously (17) . All in vitro reactions were performed under constant concentrations of AAs (0.3 mM) and dNp (4 mM) as CT-DNA to ensure Co-chromatographic analysis on PEI-cellulose plates of adduct spot 5 generated by peroxidases ( Figure 2E,F) with adduct levels easily detectable by the 32 P-post-labelling method (RAL range 1 adduct in 10 5 -10 8 nucleotides for enzymatic dA-AAII showed identical migration. In contrast, analysis of spot 5 on HPLC (Figure 3 ) resulted in a peak eluting with a reactions). Because enrichment of AA-DNA adducts by nbutanol extraction yielded a lower recovery (80-90%) as retention time (r.t.) of 14.5 min, clearly different from the r.t. of the dA-AAII standard, spot 3 (19 min). Besides spot 5 compared to the nuclease P1 version of the 32 P-post-labelling assay, all experiments were carried out with enrichment by another structurally unknown spot, spot 8, was produced only by the peroxidases (Figure 2E,F) . nuclease P1 except for incubations with zinc where the standard procedure (22) was employed due to the high adduct levels.
Spot 1 assigned to the dG-AAI adduct was separated into two peaks of radioactivity in HPLC analysis (Figure 3) . The It is clear from Figure 2 that AAI activated by five different in vitro systems generated the same two major DNA adduct minor peak with a r.t. of 32 min corresponds to the r.t. of the dA-AAI adduct. This may be due to tailing of spot 2 (dAspots (spots 1 and 2) when resolved by TLC as those obtained in vivo and reported previously (6, 17) . The activation systems AAI) in D4 direction on PEI-cellulose. As shown for AAI, the AAII-DNA adducts previously found consisting of CT-DNA, AAI and rat liver microsomes, XO, or chemical reduction by zinc produced DNA adduct patterns by 32 P-post-labelling in vivo (6, 17) were also detected and identified in each of the five in vitro activation systems (Figure qualitatively identical to that found in vivo, with two major spots and one minor spot (spot 3). Spot 3 was not detected after 4). Therefore, spot 3 represents the dA-AAII adduct and spot 4 represents the dG-AAII adduct as shown by HPLC in Figure  activation by HRP or lactoperoxidase, but several additional minor spots appeared. Adduct patterns of the different enzymatic 5. Control incubations were conducted as described above for experiments with AAI and were again free of adduct spots. activation systems obtained under aerobic incubation conditions were only quantitatively different from those performed under dA-AAII and dG-AAII were found to be the major adducts Figure 3 . Separation of 32 P-labelled nucleoside 3Ј,5Ј-bisphosphate adducts derived from AAI on a phenyl-modified reversed-phase column. Chromatographic conditions are described in Materials and methods. Adduct spots were excised and extracted from PEI-plates, dissolved and injected. Standards were obtained from in vitro incubations as described (17) . For clarity, HPLC profiles are shown in arbitrary units. formed in all incubations except when HRP and H 2 O 2 were used as the activating system. In this case two extra spots 6 and 7 located closer to the origin of the plate were generated predominantly ( Figure 4E ). The same adducts, although in trace amounts were also detectable in DNA after lactoperoxidasemediated activation of AAII ( Figure 4F ). As in the case of dG-AAI, spot no. 3 in Figure 4B ,E corresponding to the dA-AAII adduct (r.t. 19 min) contained a minor product with r.t. 14.5 min ( Figure 5 ). This product was observed upon the activation of AAII by microsomes and peroxidase as well as in vivo (17) , but was absent upon reductive activation of AAII by XO or Zn.
Quantitative analysis (Tables I and II) revealed that the extent of DNA modification by AAI activated by the three enzymatic systems was higher than by AAII under anaerobic and aerobic conditions. Under the conditions used in this study XO with hypoxanthine was the most effective enzymatic of adduct formation due to air was observed in all systems tested, being the highest for the dG-AAII and the dA-AAII adducts formed by peroxidases (Table II) . Discussion The chemical activation by a large excess of zinc-dust at pH 5.8 proved to be the most efficient activation for both AA-DNA adduct formation has proven a useful tool to monitor exposure of reactive metabolites of this plant carcinogen in vivo AAs, being 2-3 orders of magnitude higher than the most effective enzymatic activation (Tables I and II) . In reactions (2,6,17). Based on the structures of the adducts identified, we reported a reductive metabolism of AAI and AAII to the with reduction of AAI by Zn guanine adduct formation was strongly favoured over adenine adduct formation. Zinc corresponding aristolactams I and II as the main activating pathway in animals (15) (16) (17) and in humans (2). Moreover, an activation was the only system yielding more total binding of AAII than AAI to DNA.
intermediate cyclic nitrenium ion with a delocalized positive charge was postulated by us as the ultimate electrophilic Under the conditions used aerobic activation of AAI and AAII with hepatic microsomes generated adduct profiles almost species finally leading to binding, via the C7, to the exocyclic amino groups of dG and dA as shown in Figure 1 . duplicating the ones found in the forestomach of rats treated with pure AAI or pure AAII. In these two systems the dAUtilization of in vitro activation systems coupled with DNA adduct analyses provide the possibility of identifying enzymes AA adducts were always the major adducts formed. This is exemplified by the ratio of the dA-AAI adduct to the dG-AAI that can participate in the activation of genotoxic compounds like the two AAs. Since the balance between detoxication and adduct of 1.9 and the ratio of the dA-AAII adduct to the dG-AAII adduct of 4, both in vivo and after microsomal activation.
bioactivation of AAs in a particular tissue should be highly dependent on the activities of the different enzymes present, identified as products resulting from the reduction of the nitrogroup present in both acids (15, 16) . For the systems detailed knowledge of the catalytic specificities of individual enzymes converting AAs is of major importance. The present known to have reducing activities such as XO, microsomes and Zn these results were in agreement with reports of the study shows a comparison of the in vitro formation of DNA adducts from AAs activated by four enzymatic systems and in vitro reductive activation of other nitro-aromatics (9,10,12,13; W.Pfau et al., in preparation), but were unexpected zinc-dust.
All in vitro activation systems tested are able to generate for the peroxidases. The significantly higher level of DNA binding of AAI AA-DNA adducts, which were chromatographically indistinguishable from adducts formed in vivo (2,17) and previously compared to AAII in in vitro enzymatic systems can be explained by a different enzymatic conversion of both carcinooxidative reactions led to the formation of the same dA-AA and dG-AA adducts as those formed by reductive reactions. gens. AAII is probably not as good a substrate of the enzymes used. However, reductive activation by Zn leads to higher Therefore, the used peroxidase systems have nitroreductase activity for AAs under the conditions used. This finding AAII binding which is due to the absence of the methoxy group at C8 in AAII in comparison to AAI. strongly relies on the analytical method used to identify adducts. We feel, that chromatographic identical properties of In vitro activation by Zn under mildly acidic pH was by far the most efficient system for both AAs, resulting in total adducts generated by HRP with those of adducts generated by a purely chemical system (Zn) in two independent systems is adduct levels of 2-5 per 1000 nucleotides. Because of the high adduction and the simplicity of this system we have used Zn strong, although indirect evidence for structural identity. As yet we can only speculate about the chemical mechanism of successfully to synthesize adduct site specific oligonucleotides containing AAI or AAII for primer extension studies (25, 26) .
this peroxidase-mediated AA activation. It has been established that in the presence of hydrogen peroxide, peroxidases catalyse The most effective enzymatic system for in vitro activation of AAI under the conditions used was XO followed by HRP, one-electron oxidations. An important feature of this process is the formation of free radical intermediates, as clearly hepatic microsomal enzymes and lactoperoxidase. Anaerobic incubations of AAII with HRP generated the highest total demonstrated by ESR techniques (30,31). The free radicals thus formed are very reactive and act as strong reductants or binding of AAII to CT-DNA. In this case an as yet unknown adduct (spot 6) was the main adduct formed. Because oxidative oxidants (32, 33) . Beside known dG-AA and dA-AA adducts, peroxidasemetabolism, similar to that for other nitro-substituted polycyclic compounds (27) is conceivable, spot 6 might originate from mediated reaction of AAs led to the formation of additional adducts, which were not formed by XO or microsomes (adducts this metabolic pathway. However, the strong inhibition of formation of spot 6 in air (80%) argues against this hypothesis.
no. 5 and 8 from AAI in Figure 2 E,F, and adducts no. 6 and 7 from AAII in Figure 3E ,F). Oxygen strongly inhibits the Previous experiments with rats showed the major adduct formed from AAI with DNA in all organs tested to be a dA formation of the major dA and dG adducts and adduct spots 5, 6 and 7, but not spot 8 formed from AAI by lactoperoxidase derivative (6) . In vitro only hepatic microsomes generated the same ratio of dA-AAI to dG-AAI as that found in vivo. In the (Table I ). It could thus be an oxidation product of peroxidase and AAI. other systems, particularly by the reduction of AAI with zinc, dG-AAI was formed predominantly. The microsomal activation
The adduct spot no. 3 of DNA modified with AAII in vivo or after activation by microsomes and peroxidase was shown was carried out at pH 7.4 and the other activations at mildly acidic pH (pH 5.8-6.0). The different pHs are probably the to contain two products unresolved on TLC, but with distinct chromatographic properties on phenyl reversed-phase material. reason for the different reactivities of the ultimate carcinogen formed from AAI with dA and dG in DNA. In contrast, the This additional product was not obtained upon reductive activation of AAII by XO or by zinc. Although the structure major adduct formed from AAII with DNA in all in vitro activation systems, with the exception of HRP activation, was of this more polar, minor product remains to be resolved, it might be speculated to be also a product of oxidative activation always the dA-AAII adduct, the predominant adduct in vivo.
The structures of the AA-DNA adducts point to a fourof AAII. Furthermore, the structurally unknown adduct no. 5 in DNA modified with AAI activated by peroxidases eluted electron reduction mechanism of AAs to cyclic hydroxamic acids (15) . Like other nitro-aromatic compounds, the nitro with the same retention time (14.5 min), as the above unknown adduct. group of AA should undergo one-electron reduction to form the nitro anion radical, which can undergo another one-electron As shown and discussed previously (17) for the formation of dA-AAII in the forestomach of AAI-treated rats, dA-AAII reduction to form the nitroso group. This group can be further reduced by two electrons to form N-hydroxyaristolactam and (spot 3) was produced from AAI in all activation systems, except with peroxidases. It is worth mentioning that this water (15) .
The AA reductase activity of all enzymes is significantly adduct, which is formally the demethoxylation product of AAI, is not detectable in reactions with peroxidases known to decreased under aerobic conditions. This finding indirectly confirms the formation of a nitro anion radical. Oxygen would mediate demethoxylation reactions in the metabolism of oand p-anisidines (34). re-oxidize this reactive intermediate to form superoxide anion radical and parent AA as it was described for other compounds
The present study shows that XO, microsomal enzymes (P450 and NADPH:P450 oxidoreductase) and even peroxidases are earlier (28,29). Indeed, we found that superoxide dismutase, the enzyme responsible for dismutation of superoxide anion effective enzymatic systems able to activate carcinogenic AAs to form the same dG-and dA-adducts in exogenous DNA as radicals decreases the inhibitory effect of oxygen on formation of DNA adducts by AAs activated by XO, as well as by those formed in vivo in rodents (14, 15, 17) and in humans (2). The question on the relative contributions of the individual microsomes (M. Stiborova et al., in preparation).
It is well known that xanthine oxidoreductase or microsomal enzyme systems to the bioactivation of AAs in humans or rodents remains to be answered. This is the first report NADPH:cytochrome P450 reductase and even cytochrome P450 alone catalyse nitroreduction of several nitrocompounds demonstrating the activation of a nitro-aromatic compound to form DNA adducts by peroxidases as detected by 32 P-postin mammalian tissues (10) . At present we cannot quantitate the contributions of the NADPH:cytochrome P450 reductase labelling. Further studies are in progress to show if other nitroaromatics behave in the same way. and cytochrome P450 to the reduction of AAs in the microsomes used in our experiments. This we plan to resolve in the next phase of the work. Further studies with specific inhibitors References of P450s and/or NADPH:P450 reductase are already in 
